Immunotherapy with immune checkpoint inhibitors (ICI) is increasingly employed in oncology. National and international endocrine and oncologic scientific societies have provided guidelines for the management of endocrine immune-related adverse events. However, guidelines recommendations differ according to the specific filed, particularly pertaining to recommendations for the timing of endocrine testing. In this position paper, a panel of experts of the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), and Italian Society of Pharmacology (SIF) offers a critical multidisciplinary consensus for a clear, simple, useful, and easily applicable endocrine-metabolic assessment checklist for cancer patients on immunotherapy.
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: a proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group / Zatelli, Maria Chiara; Faggiano, Antongiulio; Argentiero, Antonella; Danesi, Romano; D'Oronzo, Stella; Fogli, Stefano; Franchina, Tindara; Giorgino, Francesco; Marrano, Nicola; Giuffrida, Dario; Gori, Stefania; Marino, Giampiero; Mazzilli, Rossella; Monami, Matteo; Montagnani, Monica; Morviducci, Lelio; Natalicchio, Annalisa; Ragni, Alberto; Renzelli, Valerio; Russo, Antonio; Sciacca, Laura; Tuveri, Enzo; Aimaretti, Gianluca; Avogaro, Angelo; Candido, Riccardo; Di Maio, Massimo; Silvestris, Nicola; Gallo, Marco. - In: CANCER TREATMENT REVIEWS. - ISSN 0305-7372. - 8:7(2024), pp. 1-9. [10.1016/j.ctrv.2024.102734]
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: a proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
Faggiano, Antongiulio;Mazzilli, Rossella;Morviducci, Lelio;Renzelli, Valerio;
2024
Abstract
Immunotherapy with immune checkpoint inhibitors (ICI) is increasingly employed in oncology. National and international endocrine and oncologic scientific societies have provided guidelines for the management of endocrine immune-related adverse events. However, guidelines recommendations differ according to the specific filed, particularly pertaining to recommendations for the timing of endocrine testing. In this position paper, a panel of experts of the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), and Italian Society of Pharmacology (SIF) offers a critical multidisciplinary consensus for a clear, simple, useful, and easily applicable endocrine-metabolic assessment checklist for cancer patients on immunotherapy.| File | Dimensione | Formato | |
|---|---|---|---|
|
Zatelli_Endocrine-metabolic_2024.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
2.66 MB
Formato
Adobe PDF
|
2.66 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
